Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5) - Nauck, M; Weinstock, R S; Umpierrez, G E (Diabetes Care, 2014)
et al